Journal of Peking University(Health Sciences) >
Ubiquitin-specific protease 42 regulates osteogenic differentiation of human adipose-derived stem cells
Received date: 2023-10-08
Online published: 2024-02-06
Supported by
National Natural Science Foundation of China(82071089);National Natural Science Foundation of China(82001013)
Objective: To explore the effect of ubiquitin-specific protease 42 (USP42) on osteogenic differentiation of human adipose-derived stem cells (hASCs) in vivo and in vitro. Methods: A combination of experiments was carried out with genetic depletion of USP42 using a lentiviral strategy. Alkaline phosphatase (ALP) staining and quantification, alizarin red S (ARS) staining and quantification were used to determine the osteogenic differentiation ability of hASCs under osteogenic induction between the experimental group (knockdown group and overexpression group) and the control group. Quantitative reverse transcription PCR (qRT-PCR) was used to detect the expression levels of osteogenesis related genes in the experimental group and control group, and Western blotting was used to detect the expression levels of osteogenesis related proteins in the experimental group and control group. Nude mice ectopic implantation experiment was used to evaluate the effect of USP42 on the osteogenic differentiation of hASCs in vivo. Results: The mRNA and protein expressions of USP42 in knockdown group were significantly lower than those in control group, and those in overexpression group were significantly higher than those in control group. After 7 days of osteogenic induction, the ALP activity in the knockdown group was significantly higher than that in the control group, and ALP activity in overexpression group was significantly lower than that in control group. After 14 days of osteogenic induction, ARS staining was significantly deeper in the knockdown group than in the control group, and significantly lighter in overexpression group than in the control group. The results of qRT-PCR showed that the mRNA expression levels of ALP, osterix (OSX) and collagen type Ⅰ (COLⅠ) in the knockdown group were significantly higher than those in the control group after 14 days of osteogenic induction, and those in overexpression group were significantly lower than those in control group. The results of Western blotting showed that the expression levels of runt-related transcription factor 2 (RUNX2), OSX and COLⅠ in the knockout group were significantly higher than those in the control group at 14 days after osteogenic induction, while the expression levels of RUNX2, OSX and COLⅠ in the overexpression group were significantly lower than those in the control group. Hematoxylin-eosin staining of subcutaneous grafts in nude mice showed that the percentage of osteoid area in the knockdown group was significantly higher than that in the control group. Conclusion: Knockdown of USP42 can significantly promote the osteogenic differentiation of hASCs in vitro and in vivo, and overexpression of USP42 significantly inhibits in vivo osteogenic differentiation of hASCs, and USP42 can provide a potential therapeutic target for bone tissue engineering.
Yuan PAN , Hang GU , Han XIAO , Lijun ZHAO , Yiman TANG , Wenshu GE . Ubiquitin-specific protease 42 regulates osteogenic differentiation of human adipose-derived stem cells[J]. Journal of Peking University(Health Sciences), 2024 , 56(1) : 9 -16 . DOI: 10.19723/j.issn.1671-167X.2024.01.003
| 1 | Lin H , Sohn J , Shen H , et al. Bone marrow mesenchymal stem cells: Aging and tissue engineering applications to enhance bone healing[J]. Biomaterials, 2019, 203, 96- 110. |
| 2 | Bunpetch V , Zhang Z Y , Zhang X , et al. Strategies for MSC expansion and MSC-based microtissue for bone regeneration[J]. Biomaterials, 2019, 196, 67- 79. |
| 3 | 刘云松, 周永胜, 葛雯姝, 等. 原代人脂肪基质细胞体内成骨能力的检测[J]. 北京大学学报(医学版), 2012, 44 (1): 55- 58. |
| 4 | 周永胜, 刘云松, 葛雯姝, 等. 人脂肪基质细胞在骨组织工程学中的应用[J]. 北京大学学报(医学版), 2012, 44 (1): 160- 162. |
| 5 | Snyder NA , Silva GM . Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response[J]. J Biol Chem, 2021, 297 (3): 101077. |
| 6 | Ge F , Li Y , Yuan T , et al. Deubiquitinating enzymes: Promising targets for drug resistance[J]. Drug Discov Today, 2022, 27 (9): 2603- 2613. |
| 7 | Wang X . Stem cells in tissues, organoids, and cancers[J]. Cell Mol Life Sci, 2019, 76 (20): 4043- 4070. |
| 8 | Guo YC , Zhang SW , Yuan Q . Deubiquitinating enzymes and bone remodeling[J]. Stem Cells Int, 2018, 2018, 3712083. |
| 9 | Suresh B , Lee J , Kim H , et al. Regulation of pluripotency and differentiation by deubiquitinating enzymes[J]. Cell Death Differ, 2016, 23 (8): 1257- 1264. |
| 10 | Tang YM , Lv LW , Li WY , et al. Protein deubiquitinase USP7 is required for osteogenic differentiation of human adipose-derived stem cells[J]. Stem Cell Res Ther, 2017, 8 (1): 186. |
| 11 | Hock AK , Vigneron AM , Vousden KH . Ubiquitin-specific peptidase 42 (USP42) functions to deubiquitylate histones and regulate transcriptional activity[J]. J Biol Chem, 2014, 289 (50): 34862- 34870. |
| 12 | Hock AK , Vigneron AM , Carter S , et al. Regulation of p53 stability and function by the deubiquitinating enzyme USP42[J]. EMBO J, 2011, 30 (24): 4921- 4930. |
| 13 | Giebel N , De Jaime-Soguero A , Garcia Del Arco A , et al. USP42 protects ZNRF3/RNF43 from R-spondin-dependent clearance and inhibits Wnt signalling[J]. EMBO Rep, 2021, 22 (5): e51415. |
| 14 | Orkin SH , Hochedlinger K . Chromatin connections to pluripotency and cellular reprogramming[J]. Cell, 2011, 145 (6): 835- 850. |
| 15 | Atlasi Y , Stunnenberg HG . The interplay of epigenetic marks during stem cell differentiation and development[J]. Nat Rev Genet, 2017, 18 (11): 643- 658. |
| 16 | Reyes-Thrcu FE , Wilkinson KD . Polyubiquitin binding and dis-assembly by deubiquitinating enzymes[J]. Chem Rev, 2009, 109 (4): 1495- 1508. |
| 17 | Frezza M , Schmitt S , Dou QP . Targeting the ubiquitin-proteasome pathway: An emerging concept in cancer therapy[J]. Curr Top Med Chem, 2011, 11 (23): 2888- 2905. |
| 18 | Das T , Shin SC , Song EJ , et al. Regulation of deubiquitinating enzymes by post-translational modifications[J]. Int J Mol Sci, 2020, 21 (11): 4028. |
| 19 | Sun X , Xie Z , Ma Y , et al. TGF-beta inhibits osteogenesis by upregulating the expression of ubiquitin ligase SMURF1 via MAPK-ERK signaling[J]. J Cell Physiol, 2018, 233 (1): 596- 606. |
| 20 | Rahman MS , Akhtar N , Jamil HM , et al. TGF-beta/BMP signaling and other molecular events: Regulation of osteoblastogenesis and bone formation[J]. Bone Res, 2015, 3, 15005. |
| 21 | Fan Y , Hanai JI , Le PT , et al. Parathyroid hormone directs bone marrow mesenchymal cell fate[J]. Cell Metab, 2017, 25 (3): 661- 672. |
| 22 | Lim KE , Park NR , Che X , et al. Core binding factor beta of osteoblasts maintains cortical bone mass via stabilization of Runx2 in mice[J]. J Bone Miner Res, 2015, 30 (4): 715- 722. |
| 23 | Mishra R , Kumawat KL , Basu A , et al. Japanese encephalitis virus infection increases USP42 to stabilize TRIM21 and OAS1 for neuroinflammatory and anti-viral response in human microglia[J]. Virology, 2022, 573, 131- 140. |
| 24 | Matsui M , Sakasai R , Abe M , et al. USP42 enhances homologous recombination repair by promoting R-loop resolution with a DNA-RNA helicase DHX9[J]. Oncogenesis, 2020, 9 (6): 60. |
| 25 | Liu S , Wang T , Shi Y , et al. USP42 drives nuclear speckle mRNA splicing via directing dynamic phase separation to promote tumorigenesis[J]. Cell Death Differ, 2021, 28 (8): 2482- 2498. |
/
| 〈 |
|
〉 |